Detailed answers about ICAME PHARMA LAB LIMITED, including incorporation, status, business activity, and accounts information.
When was ICAME PHARMA LAB LIMITED founded?
ICAME PHARMA LAB LIMITED was officially incorporated on 23 April 2026 and is registered under company number 17175565. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ICAME PHARMA LAB LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ICAME PHARMA LAB LIMITED?
ICAME PHARMA LAB LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ICAME PHARMA LAB LIMITED do?
ICAME PHARMA LAB LIMITED operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 46510 - Wholesale of computers, computer peripheral equipment and software, 47110 - Retail sale in non-specialised stores with food, beverages or tobacco predominating, 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is ICAME PHARMA LAB LIMITED's registered address?
The registered office address of ICAME PHARMA LAB LIMITED is 128 City Road, London, United Kingdom, EC1V 2NX. This is the official address filed with Companies House for legal and statutory correspondence.
Is ICAME PHARMA LAB LIMITED financially stable?
Financial accounts for ICAME PHARMA LAB LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.